Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. GE HealthCare Technologies's current 3-Year Share Buyback Ratio was -0.10%.
The historical rank and industry rank for GE HealthCare Technologies's 3-Year Share Buyback Ratio or its related term are showing as below:
GEHC'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -0.2 Med: -0.05 Max: 0.1
Current: -0.1
During the past 7 years, GE HealthCare Technologies's highest 3-Year Share Buyback Ratio was 0.10%. The lowest was -0.20%. And the median was -0.05%.
GEHC's 3-Year Share Buyback Ratio is ranked better than 77.78% of 612
companies
in the Medical Devices & Instruments industry
Industry Median: -2.6
vs GEHC: -0.10
GE HealthCare Technologies (NAS:GEHC) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
GE HealthCare Technologies 3-Year Share Buyback Ratio Related Terms
GEHC vs DXCM, STE, ZBH: 3-Year Share Buyback Ratio Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies 3-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's 3-Year Share Buyback Ratio falls into.
GE HealthCare Technologies 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -0.10 mean?
GE HealthCare Technologies (GEHC) has a 3-Year Share Buyback Ratio of -0.10 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for GE HealthCare Technologies and its competitors. According to the industry distribution chart, GE HealthCare Technologies ranks #136 out of 612 companies in the Medical Devices & Instruments industry, placing it in the top 22.2%.
Is GE HealthCare Technologies' 3-Year Share Buyback Ratio too high?
GE HealthCare Technologies' current 3-Year Share Buyback Ratio is -0.10. Based on the distribution chart, GE HealthCare Technologies ranks #136 out of 612 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' 3-Year Share Buyback Ratio compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #136 out of 612 companies for 3-Year Share Buyback Ratio. This places GE HealthCare Technologies in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for GE HealthCare Technologies and its competitors. GE HealthCare Technologies's current 3-Year Share Buyback Ratio is -0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $84.22, compared to a current price of $74.54 — trading 11.5% below its estimated fair value. The current 3-Year Share Buyback Ratio is -0.10. GE HealthCare Technologies' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For GE HealthCare Technologies (GEHC), the current 3-Year Share Buyback Ratio is -0.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of $74.54 is trading 11.5% below its estimated GF Value™ of $84.22.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for GEHC:
3-Year Share Buyback Ratio: -0.10
GF Value™: $84.22 vs. price of $74.54 (11.5% below fair value)
No single metric tells the full story. See the GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
75GF Score
Get the complete analysis for GEHC
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GEHC has been successfully added to your 
